Proposed Revision Of The Staging Classification For Esophageal Cancer

Slides:

Advertisements

Similar presentations

Esophageal Cancer CHEST

Advertisements

The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer.

Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma Yingjie.

Stephen R. Broderick, MD, MPHS

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography Walter.

Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma Clive J. Kelty, MB, ChB, PhD, FRCSEd,

Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C

Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than.

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: Implications for therapy John J. Nigro, MD, Jeffrey.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Tumors of the esophagogastric junction

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Appraisal of a Revised Lymph Node Classification System for Esophageal Squamous Cell Cancer Dipok Kumar Dhar, PhD, Shinji Hattori, MD, Yasuhito Tonomoto,

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy Morihito Okada, MD, Hiroyuki Yamagishi,

Nael Martini, MDa, Manjit S. Bains, MDa, Michael E

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis

Boundary between N1 and N2 Lymph Node Descriptors in the Subcarinal Zone in Lower Lobe Lung Cancer: A Brief Report Mitsuhiro Isaka, MD, Haruhiko Kondo,

The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer.

Esophageal Ultrasound-Controlled Fine Needle Aspiration for Staging of Mediastinal Lymph Nodes in Patients with Resectable Lung Cancer: Do We Always See.

Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J

Prognostic Factors in Patients with Pathologic T1-2N1M0 Disease in Non-small Cell Carcinoma of the Lung Katsunari Matsuoka, MD, Shinichi Sumitomo, MD,

Erythromycin stimulates gastric emptying after esophagectomy with gastric replacement: A randomized clinical trial Michael Burt, MD, PhDa, Andrew Scott,

Refining esophageal cancer staging

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition Sai-Hong.

Lobectomy improves ventilatory function in selected patients with severe COPD1 Robert J Korst, MD, Robert J Ginsberg, MD, Maneesh Ailawadi, MD, Manjit.

Primary repair of rupture of a main and lobar bronchus

Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non–small cell.

Support Your Specialty

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Video-Assisted Thoracoscopic Surgery is More Favorable Than Thoracotomy for Resection of Clinical Stage I Non-Small Cell Lung Cancer Bryan A. Whitson,

Results of surgical intervention for p-stage IIIA (N2) non–small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with.

Prognostic assessment of 1310 patients with non–small-cell lung cancer who underwent complete resection from 1980 to 1993 Kunihiko Inoue, MDa, Masami.

Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed Emanuela Taioli, MD, PhD, Raja Flores, MD

Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma Yingjie.

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients Raja.

Stephen R. Broderick, MD, MPHS

Nael Martini, MDa, Muhammad B. Zaman, MDb, Manjit S

Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: Data from the Surveillance Epidemiology.

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: Initial results Manjit S. Bains, MDa, Alexander Stojadinovic,

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Nabil P. Rizk, MD, Venkatraman E. Seshan, PhD, Manjit S

Yuji Tachimori, MD, Hoichi Kato, MD, Hiroshi Watanabe, MD

The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the.

Frequency and Prognostic Significance of Preoperatively Detected Enlarged Regional Lymph Nodes in Patients with Pathological Stage I Non-small Cell Lung.

It’s All in the “Swerve of the Curve”

N1 esophageal carcinoma: The importance of staging and downstaging

Combined thoracoscopic/laparoscopic staging of esophageal cancer

Carcinoma of the esophagus: Prognostic significance of histologic type

Nael Martini: A Leader in Thoracic Surgical Oncology

A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma Valerie W. Rusch, MDa, Kenneth.

Superior sulcus lung tumors: Impact of local control on survival

The future of cardiac surgery training: A survival guide

Neal S Goldstein, MD The Annals of Thoracic Surgery

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Prognostic factors and long-term results after thymoma resection: A series of 307 patients Jean-François Regnard, MDa, Pierre Magdeleinat, MDa, Christian.

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Alexander H. Moskovitz, MD, Nabil P

Nael Martini, MDa, Valerie W. Rusch, MDa, Manjit S. Bains, MDa, Mark G

Michael J. Weyant, MD, Manjit S

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Presentation transcript:

Proposed Revision Of The Staging Classification For Esophageal Cancer Robert J. Korst, MDa, Valerie W. Rusch, MDa, Ennapadam Venkatraman, PhDb, Manjit S. Bains, MDa, Michael E. Burt, MD, PhDa, Robert J. Downey, MDa, Robert J. Ginsberg, MDa The Journal of Thoracic and Cardiovascular Surgery Volume 115, Issue 3, Pages 660-670 (March 1998) DOI: 10.1016/S0022-5223(98)70332-0 Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 1 Lymph node mapping system for esophageal cancer. RUL, Right upper lobe; LUL, left upper lobe. Stations 11 (interlobar), 12 (lobar), 13 (segmental), and 14 (subsegmental) are intrapulmonary nodes and have been excluded. (From Casson AG, Rusch VW, Inculet RI, Ginsberg RJ, Zankowicz N, Rosenberg JC, et al. Lymph node mapping for resectable carcinoma of the esophagus: a guide for thoracic surgeons. Princeton (NJ): Bristol-Myers Oncology Division; 1992. Reproduced with permission.) The Journal of Thoracic and Cardiovascular Surgery 1998 115, 660-670DOI: (10.1016/S0022-5223(98)70332-0) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 2 A, Overall survival according to TNM stage. The revised staging system is noted in parentheses. B,Overall survival according to the newly proposed stage groupings with the revised TNM system. Table V describes stage groupings. Stage IV (T4, any N, M0 and any T, any N, M1) is not depicted. The Journal of Thoracic and Cardiovascular Surgery 1998 115, 660-670DOI: (10.1016/S0022-5223(98)70332-0) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 2 A, Overall survival according to TNM stage. The revised staging system is noted in parentheses. B,Overall survival according to the newly proposed stage groupings with the revised TNM system. Table V describes stage groupings. Stage IV (T4, any N, M0 and any T, any N, M1) is not depicted. The Journal of Thoracic and Cardiovascular Surgery 1998 115, 660-670DOI: (10.1016/S0022-5223(98)70332-0) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 3 A, Disease-free survival according to TNM stage. The revised staging system is noted in parentheses. B,Disease-free survival according to the newly proposed stage groupings with the revised TNM system. Table V describes stage groupings. Stage IV (T4, any N, M0 and any T, any N, M1) is not depicted. The Journal of Thoracic and Cardiovascular Surgery 1998 115, 660-670DOI: (10.1016/S0022-5223(98)70332-0) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 3 A, Disease-free survival according to TNM stage. The revised staging system is noted in parentheses. B,Disease-free survival according to the newly proposed stage groupings with the revised TNM system. Table V describes stage groupings. Stage IV (T4, any N, M0 and any T, any N, M1) is not depicted. The Journal of Thoracic and Cardiovascular Surgery 1998 115, 660-670DOI: (10.1016/S0022-5223(98)70332-0) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 4 A, Overall survival according to number of positive lymph nodes. B,Overall survival curves of patients with significantly different prognoses according to the number of positive lymph nodes. The Journal of Thoracic and Cardiovascular Surgery 1998 115, 660-670DOI: (10.1016/S0022-5223(98)70332-0) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 4 A, Overall survival according to number of positive lymph nodes. B,Overall survival curves of patients with significantly different prognoses according to the number of positive lymph nodes. The Journal of Thoracic and Cardiovascular Surgery 1998 115, 660-670DOI: (10.1016/S0022-5223(98)70332-0) Copyright © 1998 Mosby, Inc. Terms and Conditions